KRAS and colorectal carcinoma: In conclusion, the results of the current study suggest that a high concordance exists between the results of KRAS mutation analysis performed in primitive and metastatic or recurrent neoplastic tissues in primitive and metastatic, or recurrent neoplastic tissues of patients with advanced CRC.